bioAffinity Technologies BIAF
NASDAQ BIAF
$3.26 -0.31 (-8.68%)
As of: Oct 22, 2026 · 11:22 AM EDT

bioAffinity Technologies (BIAF) Short term Debt (2022 - 2023)

Updated

bioAffinity Technologies' Short term Debt was $42,334 in Q2 2023, down 74.9% from the prior quarter.

Analysis

bioAffinity Technologies (BIAF) Short term Debt (2022 - 2023) Analysis & Trends

At the end of FY2022, Short term Debt at bioAffinity Technologies came in at $251,746.

  • Per Business Quant data, BIAF's Short term Debt in the three quarters before Q2 2023 was $168,430 (Q1 2023), $251,746 (Q4 2022) and $490,117 (Q3 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 101.42 Bn 97.43 Bn -
2 Natera 57.12 Bn 52.80 Bn 485.19 Mn
3 Labcorp Holdings 26.61 Bn 24.35 Bn 1.11 Bn
4 Quest Diagnostics 26.42 Bn 24.55 Bn 1.03 Bn
5 Tenet Healthcare 22.30 Bn 11.31 Bn -
6 Guardant Health 21.74 Bn 17.80 Bn 219.03 Mn
7 Fresenius Medical Care AG 12.78 Bn 4.74 Bn 1.52 Bn
8 BrightSpring Health Services 12.58 Bn 10.91 Bn 492.75 Mn
9 Encompass Health 12.11 Bn 11.77 Bn -
10 bioAffinity Technologies 1.16 Mn -18.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 42,334.00
Mar 31, 2023 168,430.00
Dec 31, 2022 251,746.00
Sep 30, 2022 490,117.00
API Access

bioAffinity Technologies Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=BIAF&period=max&api_key=YOUR_API_KEY